ReviewFrontiers in pharmacology2026

Availability of age-stratified evidence for GLP1 receptor agonists and SGLT2 inhibitors: an analysis of European public assessment reports with a focus on older patients.

Svea Stüdemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.